(Total Views: 244)
Posted On: 10/21/2022 2:24:29 PM
Post# of 9
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Investors must not miss! ACP01 hemostemix lead clinical stage candidate will be the 1st to patient Approved StemCell Therapy for Cardiomyopathy. $HEM
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)